Cell-free Assays (IC50/Ki) for PD0325901 (Mirdametinib)

Key TargetIC50 (Cell-free)DescriptionReference
No published data available.

Cell-based Assay (IC50) for PD0325901 (Mirdametinib)

Cell TypeIC50 (Cell-based)DescriptionReference
2XSB 6.40 µM High-content drug sensitivity assay using cellular confluence as a composite metric, with AUC dose-response curves. Download PDF
ST88-14 0.77 µM High-content drug sensitivity assay using cellular confluence as a composite metric, with AUC dose-response curves. Download PDF
NMS-2PC 1.40 µM High-content drug sensitivity assay using cellular confluence as a composite metric, with AUC dose-response curves. Download PDF
NMS-2 0.91 µM High-content drug sensitivity assay using cellular confluence as a composite metric, with AUC dose-response curves. Download PDF
striatal brain slices 1.15 nM Immunohistochemistry with anti-phospho p44/p42 MAP kinase (Thr202/Tyr204) on cryo-sections; Neuronal quantification with ImageJ software. Download PDF
Check the PD0325901 (Mirdametinib) product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Jump to